Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | DRD1 | P21728 | 1/20 | 0.42 |
| ▸ | DRD3 | P35462 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
| ▸ | ABCB1 | P08183 | 7/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.38 |
| ▸ | STS | P08842 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18817857 | 0.99 | MAPT (0.41) | MAPTKMT2ALMNADRD2DRD1 | |
| SCHEMBL579429 | 0.86 | DRD2 (0.40) | MAPTKMT2ALMNADRD2DRD1 | |
| Sulfuric Acid SCHEMBL28055088 | 0.85 | DRD2 (0.52) | MAPTKMT2ALMNADRD2DRD1 | |
| SCHEMBL1734479 | 0.82 | MAPT (0.57) | MAPTKMT2ALMNAALDH1A1ELANE | |
| SCHEMBL769670 | 0.81 | DRD2 (0.57) | MAPTKMT2ADRD2DRD1DRD3 | |
| SCHEMBL30149165 | 0.81 | DRD2 (0.57) | MAPTKMT2ADRD2DRD1DRD3 | |
| SCHEMBL8431039 | 0.80 | MAPT (0.42) | MAPTKMT2ALMNADRD2DRD1 | |
| SCHEMBL29945615 | 0.80 | DRD2 (0.56) | MAPTKMT2ADRD2DRD1DRD3 | |
| SCHEMBL1161009 | 0.80 | DRD2 (0.56) | MAPTKMT2ADRD2DRD1DRD3 | |
| SCHEMBL6063472 | 0.79 | ABCB1 (0.47) | MAPTLMNADRD2DRD1DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 538 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3578162-B1 | HAIR TREATMENT METHOD | KAO CORP (JP) | 2024-06-26 | — | — | EP | claimed |
| CN-113811364-B | Hair treatment method | 花王株式会社 | 2023-09-05 | — | — | CN | claimed |
| WO-2023032110-A1 | STABILIZED SILVER-ION WATER, STABILIZED SILVER-ION WATER PRODUCTION METHOD, SILVER-ION GEL, AND SILVER-ION DETERGENT | 株式会社クリーンテック販売 | 2023-03-09 | — | — | WO | claimed |
| EP-2543356-B1 | SUNBLOCK COMPOSITION | SHISEIDO CO LTD (JP) | 2017-01-04 | — | — | EP | claimed |
| EP-2172185-B1 | Cosmetic material comprising octyl hydroxy stearate oligomer | PARAHERMOSA CO LTD (JP) | 2011-11-23 | — | — | EP | claimed |
| US-7964180-B2 | Method for enhancing effects of colorants and conditioners | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-06-21 | — | — | US | claimed |
| EP-2332512-A1 | Method for enhancing effects of colorants and conditioners | E. I. du Pont de Nemours and Company (US) | 2011-06-15 | — | — | EP | claimed |
| US-20100189670-A1 | METHOD FOR ENHANCING EFFECTS OF COLORANTS AND CONDITIONERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-29 | — | — | US | claimed |
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2010-02-25 | — | — | US | claimed |
| US-7658769-B2 | Oxidation hair dye composition | HOYU CO., LTD. (JP) | 2010-02-09 | — | — | US | claimed |
| EP-1948319-A2 | PEPTIDE-BASED ORGANIC SUNSCREENS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-07-30 | — | — | EP | claimed |
| US-20080175798-A1 | PEPTIDE-BASED HAIR PROTECTANTS | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-07-24 | — | — | US | claimed |
| WO-2008083974-A1 | ACTIVE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2008-07-17 | — | — | WO | claimed |
| WO-2008073368-A1 | PEPTIDE-BASED HAIR PROTECTANTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-06-19 | — | — | WO | claimed |
| WO-2008067928-A1 | UV ABSORBING COMPOSITIONS CONTAINING A PYRROLYLTRIAZINE | ISDIN S.A. (ES) | 2008-06-12 | — | — | WO | claimed |
| EP-1928397-A1 | METHOD FOR ENHANCING EFFECTS OF COLORANTS AND CONDITIONERS | E.I.Du pont de nemours and company (US) | 2008-06-11 | — | — | EP | claimed |
| WO-2007059076-A2 | PEPTIDE-BASED ORGANIC SUNSCREENS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-05-24 | — | — | WO | claimed |
| US-20070110686-A1 | Peptide-based organic sunscreens | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-05-17 | — | — | US | claimed |
| WO-2007038733-A1 | METHOD FOR ENHANCING EFFECTS OF COLORANTS AND CONDITIONERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-04-05 | — | — | WO | claimed |
| US-20070067924-A1 | Method for enhancing effects of colorants and conditioners | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-03-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | UGT2B17, TACR2, UGT1A1 | MAPT 922/4885KMT2A 3114/4885LMNA 1819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.